TargetCancer Foundation’s funded research in rare cancers has yielded groundbreaking discoveries published in numerous peer-reviewed journals. This consistent contribution to rare cancer knowledge underscores our commitment to expertise, authoritative research, and trustworthy information in the rare cancer community.
Featured Publication
“Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment” JCO Precision Oncology – Read Article
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
November 2012Nature Genetics
Kras-G12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma
January 2012Cancer Research